141 related articles for article (PubMed ID: 29925734)
41. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
[TBL] [Abstract][Full Text] [Related]
42. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2.
Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y
Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005
[TBL] [Abstract][Full Text] [Related]
43. Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Peptides; 2010 Jul; 31(7):1326-33. PubMed ID: 20416349
[TBL] [Abstract][Full Text] [Related]
44. [The Relationship Between GSK-3 and Mental Disorders].
Yang J; Li JF; Zhao L
Sheng Li Ke Xue Jin Zhan; 2015 Aug; 46(4):250-4. PubMed ID: 26669074
[TBL] [Abstract][Full Text] [Related]
45. Glycogen synthase kinase-3: A potential target for diabetes.
Teli DM; Gajjar AK
Bioorg Med Chem; 2023 Sep; 92():117406. PubMed ID: 37536264
[TBL] [Abstract][Full Text] [Related]
46. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
[TBL] [Abstract][Full Text] [Related]
47. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy.
Al-Damry NT; Attia HA; Al-Rasheed NM; Al-Rasheed NM; Mohamad RA; Al-Amin MA; Dizmiri N; Atteya M
Biomed Pharmacother; 2018 Nov; 107():347-358. PubMed ID: 30099338
[TBL] [Abstract][Full Text] [Related]
48. The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy.
Blankesteijn WM; van de Schans VA; ter Horst P; Smits JF
Trends Pharmacol Sci; 2008 Apr; 29(4):175-80. PubMed ID: 18342376
[TBL] [Abstract][Full Text] [Related]
49. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
50. Glycogen Synthase Kinase 3: A Kinase for All Pathways?
Patel P; Woodgett JR
Curr Top Dev Biol; 2017; 123():277-302. PubMed ID: 28236969
[TBL] [Abstract][Full Text] [Related]
51. Glycogen synthase kinase-3beta affects size of dentate gyrus and species-typical behavioral tasks in transgenic and knockout mice.
Kondratiuk I; Devijver H; Lechat B; Van Leuven F; Kaczmarek L; Filipkowski RK
Behav Brain Res; 2013 Jul; 248():46-50. PubMed ID: 23570858
[TBL] [Abstract][Full Text] [Related]
52. Regulation of p70S6k, GSK-3beta, and calcineurin in rat striated muscle during aging.
Kinnard RS; Mylabathula DB; Uddemarri S; Rice KM; Wright GL; Blough ER
Biogerontology; 2005; 6(3):173-84. PubMed ID: 16041621
[TBL] [Abstract][Full Text] [Related]
53. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
Olianas MC; Dedoni S; Onali P
Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
[TBL] [Abstract][Full Text] [Related]
54. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
[TBL] [Abstract][Full Text] [Related]
55. New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases.
Wang C; Cui Y; Xu T; Zhou Y; Yang R; Wang T
Biochem Pharmacol; 2023 Dec; 218():115923. PubMed ID: 37981175
[TBL] [Abstract][Full Text] [Related]
56. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.
Wang Q; Zhou Y; Wang X; Evers BM
Oncogene; 2006 Jan; 25(1):43-50. PubMed ID: 16278684
[TBL] [Abstract][Full Text] [Related]
57. Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions.
Saraswati AP; Ali Hussaini SM; Krishna NH; Babu BN; Kamal A
Eur J Med Chem; 2018 Jan; 144():843-858. PubMed ID: 29306837
[TBL] [Abstract][Full Text] [Related]
58. Apical membrane localization of glycogen synthase kinase 3beta protein in normal colon epithelium and aberrant distribution in colorectal cancer.
Hirakawa H; Nakayama T; Shibata K; Mihara Y; Taba M; Nagayasu T; Sekine I
Cancer Lett; 2009 Mar; 275(1):158-62. PubMed ID: 19022564
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
60. Glucocorticoids differentially modulate insulin-mediated protein and glycogen synthetic signaling downstream of protein kinase B in rat myocardium.
Wu Y; Barrett EJ; Long W; Liu Z
Endocrinology; 2004 Mar; 145(3):1161-6. PubMed ID: 14630710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
